Rhenman & Partners Asset Management AB as of Sept. 30, 2021
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 92 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Therapeutics Pub L SHS | 3.6 | $52M | 470k | 109.54 | |
| UnitedHealth (UNH) | 3.4 | $49M | 125k | 390.74 | |
| Anthem (ELV) | 3.1 | $45M | 120k | 372.80 | |
| Johnson & Johnson (JNJ) | 3.1 | $44M | 270k | 161.50 | |
| Pfizer (PFE) | 3.0 | $43M | 1.0M | 43.01 | |
| Biogen Idec (BIIB) | 3.0 | $42M | 150k | 282.99 | |
| Abbvie (ABBV) | 2.7 | $38M | 355k | 107.87 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.6 | $37M | 280k | 130.21 | |
| Thermo Fisher Scientific (TMO) | 2.4 | $34M | 60k | 571.33 | |
| Medtronic SHS (MDT) | 2.4 | $34M | 273k | 125.35 | |
| CVS Caremark Corporation (CVS) | 2.4 | $34M | 400k | 84.86 | |
| Eli Lilly & Co. (LLY) | 2.4 | $34M | 145k | 231.05 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $30M | 165k | 181.39 | |
| McKesson Corporation (MCK) | 2.1 | $30M | 148k | 199.38 | |
| Mirati Therapeutics | 1.9 | $27M | 150k | 176.91 | |
| Guardant Health (GH) | 1.8 | $26M | 205k | 125.01 | |
| Cigna Corp (CI) | 1.8 | $25M | 127k | 200.16 | |
| Boston Scientific Corporation (BSX) | 1.7 | $25M | 570k | 43.39 | |
| Abbott Laboratories (ABT) | 1.7 | $24M | 206k | 118.13 | |
| Seagen | 1.6 | $23M | 135k | 169.80 | |
| Abiomed | 1.6 | $23M | 70k | 325.51 | |
| Merck & Co (MRK) | 1.6 | $23M | 300k | 75.11 | |
| AmerisourceBergen (COR) | 1.6 | $23M | 188k | 119.45 | |
| Humana (HUM) | 1.6 | $22M | 57k | 389.16 | |
| Gilead Sciences (GILD) | 1.5 | $21M | 300k | 69.85 | |
| Intuitive Surgical Com New (ISRG) | 1.4 | $20M | 20k | 994.15 | |
| Teladoc (TDOC) | 1.3 | $19M | 150k | 126.81 | |
| Alnylam Pharmaceuticals (ALNY) | 1.3 | $19M | 100k | 188.81 | |
| Axonics Modulation Technolog (AXNX) | 1.3 | $19M | 290k | 65.09 | |
| Biohaven Pharmaceutical Holding | 1.3 | $19M | 135k | 138.91 | |
| Centene Corporation (CNC) | 1.3 | $19M | 300k | 62.31 | |
| Cooper Cos Com New | 1.3 | $19M | 45k | 413.31 | |
| BioMarin Pharmaceutical (BMRN) | 1.3 | $19M | 240k | 77.29 | |
| Apellis Pharmaceuticals (APLS) | 1.3 | $19M | 561k | 32.96 | |
| Hca Holdings (HCA) | 1.3 | $18M | 75k | 242.72 | |
| Zimmer Holdings (ZBH) | 1.2 | $18M | 120k | 146.36 | |
| Veeva Sys Cl A Com (VEEV) | 1.2 | $17M | 60k | 288.17 | |
| EXACT Sciences Corporation (EXAS) | 1.2 | $17M | 180k | 95.45 | |
| Nektar Therapeutics (NKTR) | 1.2 | $17M | 950k | 17.96 | |
| Xencor (XNCR) | 1.2 | $17M | 507k | 32.66 | |
| Intra Cellular Therapies (ITCI) | 1.1 | $16M | 430k | 37.28 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.0 | $14M | 750k | 19.21 | |
| Becton, Dickinson and (BDX) | 1.0 | $14M | 58k | 245.83 | |
| Accolade (ACCD) | 1.0 | $14M | 325k | 42.17 | |
| R1 Rcm | 0.8 | $12M | 550k | 22.01 | |
| Health Catalyst (HCAT) | 0.8 | $12M | 240k | 50.01 | |
| Tenet Healthcare Corp Com New (THC) | 0.8 | $12M | 180k | 66.44 | |
| Edwards Lifesciences (EW) | 0.8 | $12M | 105k | 113.21 | |
| Macrogenics (MGNX) | 0.8 | $11M | 545k | 20.94 | |
| Neurocrine Biosciences (NBIX) | 0.6 | $9.1M | 95k | 95.91 | |
| Revance Therapeutics (RVNC) | 0.6 | $8.9M | 320k | 27.86 | |
| Aerie Pharmaceuticals | 0.6 | $8.6M | 750k | 11.40 | |
| 1life Healthcare | 0.6 | $8.5M | 420k | 20.25 | |
| Silk Road Medical Inc Common (SILK) | 0.6 | $8.0M | 146k | 55.03 | |
| Iovance Biotherapeutics (IOVA) | 0.6 | $7.9M | 320k | 24.66 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.6 | $7.9M | 205k | 38.33 | |
| Phreesia (PHR) | 0.5 | $7.6M | 124k | 61.70 | |
| Esperion Therapeutics (ESPR) | 0.5 | $7.5M | 622k | 12.05 | |
| Bristol Myers Squibb (BMY) | 0.5 | $7.4M | 125k | 59.17 | |
| Glaukos (GKOS) | 0.5 | $7.2M | 150k | 48.17 | |
| Shockwave Med (SWAV) | 0.5 | $7.0M | 34k | 205.88 | |
| Novocure Ord Shs (NVCR) | 0.5 | $7.0M | 60k | 116.17 | |
| ImmunoGen | 0.5 | $6.9M | 1.2M | 5.67 | |
| Sangamo Biosciences (SGMO) | 0.5 | $6.9M | 765k | 9.01 | |
| Alkermes SHS (ALKS) | 0.5 | $6.5M | 210k | 30.84 | |
| Phathom Pharmaceuticals (PHAT) | 0.4 | $6.0M | 186k | 32.10 | |
| Meiragtx Holdings (MGTX) | 0.4 | $5.9M | 450k | 13.18 | |
| Iveric Bio | 0.4 | $5.7M | 350k | 16.24 | |
| Privia Health Group (PRVA) | 0.4 | $5.7M | 240k | 23.56 | |
| Myovant Sciences | 0.4 | $5.6M | 250k | 22.44 | |
| Viewray (VRAYQ) | 0.4 | $5.6M | 775k | 7.21 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.4 | $5.5M | 1.5M | 3.63 | |
| Radius Health Com New | 0.4 | $5.3M | 430k | 12.41 | |
| Cassava Sciences (SAVA) | 0.4 | $5.3M | 85k | 62.08 | |
| Sage Therapeutics (SAGE) | 0.4 | $5.1M | 115k | 44.31 | |
| Essa Pharma Com New (EPIX) | 0.3 | $4.8M | 600k | 8.00 | |
| Annexon (ANNX) | 0.3 | $4.7M | 250k | 18.61 | |
| Progyny (PGNY) | 0.3 | $4.5M | 80k | 56.00 | |
| Oak Street Health | 0.3 | $4.5M | 105k | 42.53 | |
| G1 Therapeutics (GTHX) | 0.3 | $4.4M | 325k | 13.42 | |
| Stereotaxis Com New (STXS) | 0.3 | $4.3M | 800k | 5.38 | |
| Arena Pharmaceuticals Com New | 0.3 | $3.6M | 60k | 59.55 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 0.2 | $3.4M | 140k | 24.25 | |
| Immunocore Hldgs Ads (IMCR) | 0.2 | $3.3M | 90k | 37.07 | |
| Ionis Pharmaceuticals (IONS) | 0.2 | $2.5M | 75k | 33.55 | |
| Fibrogen (FGEN) | 0.1 | $2.0M | 200k | 10.22 | |
| Deciphera Pharmaceuticals (DCPH) | 0.1 | $2.0M | 60k | 33.98 | |
| Pieris Pharmaceuticals (PIRS) | 0.1 | $1.6M | 300k | 5.17 | |
| Silverback Therapeutics (SPRY) | 0.1 | $1.5M | 150k | 9.98 | |
| Epizyme | 0.1 | $1.4M | 265k | 5.12 | |
| Innovage Hldg Corp (INNV) | 0.1 | $992k | 150k | 6.61 | |
| Acceleron Pharma | 0.1 | $756k | 4.4k | 172.13 |
